The news follows a deal announced last month between Lantern and chronic disease management company Omada Health to add the company's CBT-based therapies to launch new programs for depression and anxiety.
The startup previously developed the Sleepio application, which is targeted at insomnia, and is offered to around 12 million users through partnerships with payers and employers like Boston Medical Center, Comcast and the NHS.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company has signed a perpetual licencing deal for the software, curriculum and content of Lantern, which built digital therapeutics for mental health conditions before shutting down operations last year.
Healthcare VCs provided their thoughts on why startups die, followed by a roundup of five companies that didn't survive 2018.
The San Francisco company is folding its commercial operations on August 1 after a few acquisition deals fell through, according to TechCrunch.
University of Pittsburgh Medical Center led a $17 million Series A round for the three year-old company.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.